Gilead And Teva Drug Buyers Lose Bid For New Antitrust Trial

By Hailey Konnath · November 1, 2023, 11:54 PM EDT

A California federal judge on Wednesday refused to grant HIV medication purchasers a new trial following a jury's verdict clearing Gilead and Teva in a $3.6 billion antitrust case claiming they...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In re HIV Antitrust Litigation

Case Number

3:19-cv-02573

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

May 14, 2019